Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

QuantuMDx Group Ltd.

Point-of-care assays support personalized medicine

This article was originally published in Start Up

Executive Summary

QuantuMDx Group Ltd. is developing handheld and portable low-cost diagnostic, genomic sequencing, and proteomic platforms that it thinks will promote the practice of personalized medicine in both developed and developing countries. The company aims to create devices that can provide results within minutes at point-of-care without the need for complex sample preparation processes, and that can integrate with mobile apps for ongoing patient support and education.

Advertisement

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC092501

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel